Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,163 | 529 | 99.8% |
| Education | $15.90 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,002 | 66 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $920.96 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $856.84 | 57 | $0 (2024) |
| Medtronic, Inc. | $756.69 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $693.69 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $671.11 | 30 | $0 (2024) |
| Amgen Inc. | $613.75 | 33 | $0 (2024) |
| Edwards Lifesciences Corporation | $517.00 | 8 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $409.62 | 26 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $340.71 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,575 | 106 | Edwards Lifesciences Corporation ($378.73) |
| 2023 | $2,094 | 100 | E.R. Squibb & Sons, L.L.C. ($283.21) |
| 2022 | $1,338 | 64 | Medtronic, Inc. ($287.86) |
| 2021 | $453.38 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($107.23) |
| 2020 | $317.66 | 19 | PFIZER INC. ($92.91) |
| 2019 | $1,147 | 63 | Janssen Pharmaceuticals, Inc ($175.78) |
| 2018 | $1,355 | 86 | Novartis Pharmaceuticals Corporation ($252.12) |
| 2017 | $899.71 | 67 | Janssen Pharmaceuticals, Inc ($147.07) |
All Payment Transactions
530 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $38.30 | General |
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.57 | General |
| 12/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Not Applicable | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Boston Scientific Corporation | RESONATE EL ICD VR (Device) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: RESONATE_CRM | ||||||
| 10/30/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $124.03 | General |
| Category: Renal Denervation System | ||||||
| 10/28/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Pacemakers | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Obesity | ||||||
| 10/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Cardiovascular | ||||||
| 10/08/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Not Applicable | ||||||
| 10/01/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 09/27/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $27.01 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,412 | 4,686 | $1.0M | $251,642 |
| 2022 | 27 | 3,310 | 4,619 | $1.1M | $261,349 |
| 2021 | 33 | 3,351 | 4,783 | $1.1M | $289,441 |
| 2020 | 26 | 2,779 | 3,613 | $546,372 | $202,465 |
All Medicare Procedures & Services
140 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 726 | 1,229 | $491,404 | $117,238 | 23.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 143 | 148 | $92,648 | $23,473 | 25.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 916 | 1,505 | $69,230 | $17,048 | 24.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 119 | $43,911 | $11,212 | 25.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 204 | 204 | $42,636 | $11,144 | 26.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 93 | 151 | $37,146 | $9,672 | 26.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 63 | $33,831 | $9,062 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 45 | $25,083 | $6,199 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $27,666 | $6,039 | 21.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 92 | 103 | $17,924 | $4,552 | 25.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 73 | 73 | $17,009 | $4,488 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 67 | $19,028 | $4,424 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 44 | $13,288 | $3,555 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $11,592 | $3,102 | 26.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 26 | 29 | $8,078 | $2,018 | 25.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 21 | 22 | $7,128 | $1,908 | 26.8% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 20 | 22 | $7,392 | $1,886 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 15 | $6,645 | $1,741 | 26.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $6,868 | $1,622 | 23.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 87 | 87 | $5,655 | $1,463 | 25.9% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 17 | 17 | $5,355 | $1,432 | 26.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 70 | 70 | $5,320 | $1,410 | 26.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 106 | 106 | $4,558 | $1,186 | 26.0% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 52 | 54 | $4,266 | $1,079 | 25.3% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 14 | 14 | $2,926 | $781.76 | 26.7% |
About Dr. Sonia Baker, MD
Dr. Sonia Baker, MD is a Cardiovascular Disease healthcare provider based in Towson, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1780728170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonia Baker, MD has received a total of $10,179 in payments from pharmaceutical and medical device companies, with $2,575 received in 2024. These payments were reported across 530 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($10,163).
As a Medicare-enrolled provider, Baker has provided services to 12,852 Medicare beneficiaries, totaling 17,701 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 140 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Towson, MD
- Active Since 02/18/2007
- Last Updated 01/03/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1780728170
Products in Payments
- ENTRESTO (Drug) $846.87
- XARELTO (Drug) $840.79
- ELIQUIS (Drug) $795.98
- LifeVest (Device) $409.62
- MYCARELINK (Device) $380.96
- JARDIANCE (Drug) $356.80
- VYNDAQEL (Drug) $330.93
- Repatha (Biological) $310.98
- Corlanor (Drug) $302.77
- CAMZYOS (Drug) $278.31
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $229.78
- Vascepa (Drug) $200.90
- MULTAQ (Drug) $194.28
- Reveal LINQ (Device) $182.46
- Arcalyst (Drug) $174.89
- PRALUENT (Drug) $146.43
- FARXIGA (Drug) $146.21
- BRILINTA (Drug) $143.12
- PRALUENT ALIROCUMAB INJECTION (Biological) $137.51
- ONPATTRO (Drug) $135.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Towson
Dr. Jeremy Pollock, M.d, M.D
Cardiovascular Disease — Payments: $81,248
Dr. Nilofar Islam, Md, MD
Cardiovascular Disease — Payments: $61,601
Dr. Michael Drossner, M.d, M.D
Cardiovascular Disease — Payments: $20,792
Daniel Plotnick, Md, MD
Cardiovascular Disease — Payments: $14,868
Ronald Schechter, M.d, M.D
Cardiovascular Disease — Payments: $12,075
Dr. Michael Pressel, M.d, M.D
Cardiovascular Disease — Payments: $9,201